Activation of RAS/MEK/ERK Signaling Drives Biliary Differentiation in Primary Liver Cancer

Researchers used genetically engineered mouse models with liver-specific deletion of tumour suppressors Rb and p53 together with activation of oncogenic Kras to investigate the cell of origin in intrahepatic cholangiocarcinoma.